FDA Approves First Drug to Extend Life in Infantile NPCNovember 17, 2026 Health 3 Views The FDA approved Lembaz for infantile-onset Niemann-Pick disease type C, the first treatment shown to reduce mortality in patients with neurological symptoms starting before age 6.